Masimo Announces FDA Clearance of Neonatal Indication for O3® Regional Oximetry

82

IRVINE, Calif.–(BUSINESS WIRE)–Masimo O3® Regional Oximetry has received FDA clearance for use on infant and neonatal patients (<10 kg)….

 

 

http://www.businesswire.com/news/home/20190610005220/en/Masimo-Announces-FDA-Clearance-Neonatal-Indication-O3%C2%AE/